Chromik, A. M., Huss, S., Osseili, H., Daigeler, A., Kersting, S., Sülberg, D., . . . Müller, A. M. (2010). Oral administration of the anti-proliferative substance taurolidine has no impact on dextran sulfate sodium induced colitis-associated carcinogenesis in mice. Medknow Publications.
Παραπομπή Chicago StyleChromik, Ansgar Michael, et al. Oral Administration of the Anti-proliferative Substance Taurolidine Has No Impact On Dextran Sulfate Sodium Induced Colitis-associated Carcinogenesis in Mice. Medknow Publications, 2010.
Παραπομπή MLAChromik, Ansgar Michael, et al. Oral Administration of the Anti-proliferative Substance Taurolidine Has No Impact On Dextran Sulfate Sodium Induced Colitis-associated Carcinogenesis in Mice. Medknow Publications, 2010.